UNH weighed on the Dow as managed-care stocks sold off on proposed CMS Medicare Advantage audit and repayment rules. The investigation focuses on what shareholders were told about the Company's audit exposure.
NEW YORK, Nov. 19, 2026 /PRNewswire/ -- UnitedHealth Group Inc. (NYSE: UNH) was among the insurers dragging down the Dow Jones Industrial Average on November 18, 2026. The stock fell over 10% after the Centers for Medicare & Medicaid Services (CMS) proposed new Medicare Advantage anti-fraud and audit rules. If your UNH shares lost value in that selloff, this investigation concerns you. Shareholders who lost money are encouraged to submit your UNH loss information now . You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (888) SueWallSt.
The selling began at the opening bell on Tuesday, November 17, when UNH opened down 4.78%. By Wednesday, it had spread across managed care, with Humana and other Medicare Advantage insurers also trading lower. UnitedHealth is one of the largest participants in Medicare Advantage.
Before the proposal, market coverage of UNH centered on valuation and recent board changes. By November 18, the focus had turned to CMS audits of risk-adjustment payments and possible repayment of improper payments. The investigation concerns whether UnitedHealth may not have adequately disclosed its exposure to Medicare Advantage audits and repayment obligations.
If you lost money on UnitedHealth stock, start your UNH loss review today or call (888) SueWallSt.
WHY SUEWALLST : SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured billions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
Frequently Asked Questions About the UNH Investigation
Q: How much did UNH stock drop? A: UNH shares fell over 10% on November 18. The decline followed a CMS proposal for new Medicare Advantage anti-fraud and audit rules, including possible repayment of improper payments. Investors who purchased shares at allegedly inflated prices and suffered losses may be eligible to seek compensation.
Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether UnitedHealth Group made materially false or misleading statements about its Medicare Advantage risk-adjustment practices. It also concerns statements about the Company's exposure to CMS audits and repayment of improper payments. When CMS proposed expanded audit and repayment rules in November 2026, the stock price declined sharply.
Q: What do UNH investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery . No immediate action is required to remain eligible to participate in the investigation.
Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.
Q: What if I already sold my UNH shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought UNH and sold at a loss may still participate in the investigation.
Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either.
Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (888) SueWallSt
Fax: (212) 363-7171
Attorney Advertising. Prior results do not guarantee similar outcomes.
SOURCE SueWallSt.com

Share this article